Literature DB >> 29783333

Physician liability: the next big thing for personalized medicine?

Gary E Marchant1, Doug E Campos-Outcalt2, Rachel A Lindor3.   

Abstract

Liability is likely to be a major driver for the future direction and implementation of personalized medicine, spurring the adoption of genetic tests and other pharmacogenomic technologies, in some cases appropriately, and in other cases prematurely or as inefficient defensive medicine. While all entities in the personalized medicine chain will face liability risks, physicians will be at the greatest risk owing to their lack of defenses, limited experience in dealing with genetics and the growing disparities within the profession in implementing new medical technologies. The history of liability for genetic testing, primarily in the prenatal testing context, suggests that liability will often be both unpredictable and influential in changing medical practice. It is critical to anticipate and attempt to prevent such liability risks in a proactive manner so to minimize the disruptive impact that liability can cause.

Keywords:  BRCA; gene-expression profiling; genetics; lawsuit; liability; litigation; pharmacogenomics; physician liability; whole-genome sequencing

Year:  2011        PMID: 29783333     DOI: 10.2217/pme.11.33

Source DB:  PubMed          Journal:  Per Med        ISSN: 1741-0541            Impact factor:   2.512


  7 in total

Review 1.  Personalized medicine: is it a pharmacogenetic mirage?

Authors:  Rashmi R Shah; Devron R Shah
Journal:  Br J Clin Pharmacol       Date:  2012-10       Impact factor: 4.335

2.  Key Expert Stakeholder Perceptions of the Law of Genomics: Identified Problems and Potential Solutions.

Authors:  Fook Yee Cheung; Lauren Clatch; Susan M Wolf; Ellen Wright Clayton; Frances Lawrenz
Journal:  J Law Med Ethics       Date:  2020-03       Impact factor: 1.718

3.  Pharmacogenetic Testing Knowledge and Attitudes among Pediatric Psychiatrists and Pediatricians in Alberta, Canada.

Authors:  Chaten D Jessel; Abdullah Al Maruf; Anita Oomen; Paul D Arnold; Chad A Bousman
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2022-02-01

4.  Implications of the incidentalome for clinical pharmacogenomics.

Authors:  Kyle B Brothers; Martin Langanke; Pia Erdmann
Journal:  Pharmacogenomics       Date:  2013-08       Impact factor: 2.533

5.  Personalized medicine and genetic malpractice.

Authors:  Gary E Marchant; Rachel A Lindor
Journal:  Genet Med       Date:  2013-09-26       Impact factor: 8.822

6.  Encountering Pharmacogenetic Test Results in the Psychiatric Clinic.

Authors:  Chad A Bousman; Gouri Mukerjee; Xiaoyu Men; Ruslan Dorfman; Daniel J Müller; Roger E Thomas
Journal:  Can J Psychiatry       Date:  2021-11-16       Impact factor: 4.356

Review 7.  Mapping the incidentalome: estimating incidental findings generated through clinical pharmacogenomics testing.

Authors:  Matthew J Westbrook; M Frances Wright; Sara L Van Driest; Tracy L McGregor; Joshua C Denny; Rebecca L Zuvich; Ellen Wright Clayton; Kyle B Brothers
Journal:  Genet Med       Date:  2012-11-29       Impact factor: 8.822

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.